| Company Name: |
Hangzhou Peptidego Biotech Co.,Ltd.
|
| Tel: |
0571-87213919 |
| Email: |
Eric@peptidego.com |
| Products Intro: |
Product Name:P4pal10
CAS:1021346-05-3
Purity:95% or 98% HPLC Package:1mg；5mg；10mg；50mg；100mg,1g or according to customer's detail requirement.
|
| Company Name: |
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
|
| Tel: |
0571-87213919 17306812703 |
| Email: |
3007955328@qq.com |
| Products Intro: |
Product Name:P4pal10
CAS:1021346-05-3
Purity:95% or 98% HPLC Package:1mg；5mg；10mg；50mg；100mg,1g or according to customer's detail requirement.
|
|
| | L-Argininamide, N-(1-oxohexadecyl)-L-serylglycyl-L-arginyl-L-arginyl-L-tyrosylglycyl-L-histidyl-L-alanyl-L-leucyl- Basic information |
| | L-Argininamide, N-(1-oxohexadecyl)-L-serylglycyl-L-arginyl-L-arginyl-L-tyrosylglycyl-L-histidyl-L-alanyl-L-leucyl- Chemical Properties |
| density | 1.37±0.1 g/cm3(Predicted) | | pka | 9.82±0.15(Predicted) |
| | L-Argininamide, N-(1-oxohexadecyl)-L-serylglycyl-L-arginyl-L-arginyl-L-tyrosylglycyl-L-histidyl-L-alanyl-L-leucyl- Usage And Synthesis |
| Biological Activity | PAR4antagonist which shows no agonist activity (as measured by platelet aggregation, intracellular Ca2+release or InsP production). Also inhibits Gαi-coupled formylpeptide FPR2 receptor downstream signaling but does not inhibit downstream signaling of the Gαq-coupled P2Y2 and PAF receptors. Additionally activates the FFAR2 short chain fatty acid receptor. Inhibits platelet aggregation and shows cardioprotective effects by decreasing infarct size before ischemia. | | storage | -20°C |
| | L-Argininamide, N-(1-oxohexadecyl)-L-serylglycyl-L-arginyl-L-arginyl-L-tyrosylglycyl-L-histidyl-L-alanyl-L-leucyl- Preparation Products And Raw materials |
|